¼¼°èÀÇ »çÀÌÅäŰ´Ñ ½ÃÀå
Cytokinins
»óǰÄÚµå : 1779898
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 386 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »çÀÌÅäŰ´Ñ ½ÃÀåÀº 2030³â±îÁö 28¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 20¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »çÀÌÅäŰ´Ñ ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 28¾ï ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾Æµ¥´ÑÇü »çÀÌÅäŰ´ÑÀº CAGR 7.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 17¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Æä´ÒÇü »çÀÌÅäŰ´ÑºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 5.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 3,590¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ »çÀÌÅäŰ´Ñ ½ÃÀåÀº 2024³â¿¡ 5¾ï 3,590¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 10.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 8,610¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.0%¿Í 6.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ »çÀÌÅäŰ´Ñ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ Á¤¸®

½ÃÅäŰ´ÑÀÌ Çö´ë ³ó¾÷¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

½Ä¹° ¼ºÀå Á¶ÀýÁ¦ÀÇ ÀÏÁ¾ÀÎ »çÀÌÅäŰ´ÑÀº ¼¼Æ÷ºÐ¿­, ¼ºÀå ÃËÁø, ÀÙÀÇ ³ëÈ­ Áö¿¬¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç Çö´ë ³ó¾÷¿¡ ¾ø¾î¼­´Â ¾È µÉ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ä¹° È£¸£¸óÀº ÀÛ¹° °­È­, Á¶Á÷ ¹è¾ç, ½ºÆ®·¹½º ÀúÇ×¼º °ü¸®¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼¼°è ½Ä·® ¼ö¿ä Áõ°¡¿Í ±âÈÄ º¯È­°¡ ³ó¾÷ »ý»ê¼º¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¡¿îµ¥, »çÀÌÅäŰ´ÑÀº ÀÛ¹° ¼öÈ®·® Çâ»ó, °¡¹³ ÀúÇ×¼º °­È­, ¼öÈ® ÈÄ ÀúÀå ±â°£ ¿¬ÀåÀ» À§ÇØ È°¿ëµÇ°í ÀÖ½À´Ï´Ù.

Á¤¹Ð³ó¾÷°ú ȯ°æÁ¦¾î³ó¾÷(CEA)ÀÇ ºÎ»óÀº »çÀÌÅäŰ´ÑÀÇ Ã¤Åÿ¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿Â½Ç Àç¹è, ¼ö°æ Àç¹è, ¿¡¾î·ÎÆ÷´Ð½º¿¡¼­´Â Á¦¾îµÈ Á¶°Ç¿¡¼­ ½Ä¹°ÀÇ ¼ºÀåÀ» ÃÖÀûÈ­Çϱâ À§ÇØ »çÀÌÅäŰ´Ñ ±â¹Ý Á¦Á¦°¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¸í°øÇÐÀ» ÅëÇÑ ½Ä¹° À¯ÀüÇÐÀÇ ¹ßÀüÀº »çÀÌÅäŰ´Ñ °­È­ ¹ÙÀÌ¿À ÀÚ±ØÁ¦ÀÇ ±æÀ» ¿­¾î È­ÇÐ ºñ·á¿¡ ´ëÇÑ Áö¼Ó °¡´ÉÇÑ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ³ó¾÷ °ü·Ã ±â¾÷ ¹× ¿¬±¸±â°üÀÌ ÀÛ¹° »ý»ê·® ±Ø´ëÈ­¿¡ ÁÖ·ÂÇϰí ÀÖ¾î, ½ÃÅäŰ´Ñ ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÅäŰ´ÑÀ» Ȱ¿ëÇÑ ³ó¾÷ÀÇ Ãֽбâ¼ú Çõ½ÅÀº?

ÃÖ±Ù »çÀÌÅäŰ´Ñ Á¦Á¦ÀÇ ±â¼ú Çõ½ÅÀº ±× È¿´É°ú Àû¿ë È¿À²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î ĸ½¶È­ ±â¼úÀº ½Ä¹°¿¡ Àå½Ã°£ ÀÚ±ØÀ» ÁÖ¾î ÀæÀº »ìÆ÷ÀÇ Çʿ伺À» ÁÙ¿©ÁÖ´Â ¼­¹æÇü ½ÃÅäŰ´Ñ Á¦Ç°À» °³¹ßÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, ³ª³ë Á¦Á¦ÀÇ ¹ßÀüÀ¸·Î ½ÃÅäŰ´ÑÀÇ Èí¼ö¼ºÀÌ Çâ»óµÇ¾î ½Ä¹°·ÎÀÇ Èí¼ö¸¦ º¸ÀåÇϰí, ȯ°æÀ¸·ÎÀÇ À¯ÃâÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ µ¹ÆÄ±¸´Â ¹ÙÀÌ¿À ¿£Áö´Ï¾î¸µ ÀÛ¹°¿¡ »çÀÌÅäŰ´ÑÀ» ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. ¿¬±¸ÀÚµéÀº CRISPR°ú °°Àº À¯ÀüÀÚ ÆíÁý ±â¼úÀ» »ç¿ëÇÏ¿© ½Ä¹°ÀÇ »çÀÌÅäŰ´Ñ ¹ßÇöÀ» °­È­ÇÏ¿© ¼ºÀå ¼Óµµ Çâ»ó°ú ½ºÆ®·¹½º ³»¼º °­È­¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI¸¦ Ȱ¿ëÇÑ ³ó¾÷ ±â¼ú Ç÷§ÆûÀº Åä¾ç »óÅÂ¿Í ½Ä¹°ÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ºÐ¼®ÇÏ¿© ³óºÎµéÀÌ »çÀÌÅäŰ´Ñ »ç¿ëÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ´ë±Ô¸ð ³ó¾÷ °æ¿µ¿¡¼­ ½ÃÅäŰ´ÑÀ» º¸´Ù È¿°úÀûÀ̰í Áö¼Ó °¡´ÉÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.

½ÃÀå µ¿Çâ°ú ±ÔÁ¦ Á¤Ã¥Àº ½ÃÅäŰ´ÑÀÇ Ã¤Åÿ¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?

À¯±â³ó¾÷°ú Áö¼Ó °¡´ÉÇÑ ³ó¾÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÅäŰ´Ñ ½ÃÀå µ¿Çâ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¸¹Àº ³ó¾÷ »ý»êÀÚµéÀº ÇÕ¼º È­Çй°Áú¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀ̱â À§ÇØ ÇØÁ¶·ù ÃßÃâ¹°À̳ª ¹Ì»ý¹° ¹ÙÀÌ¿À ÀÚ±ØÁ¦¿Í °°Àº õ¿¬ »çÀÌÅäŰ´Ñ °ø±Þ¿øÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼öÁ÷³ó¹ý ¹× ½Ç³» Àç¹èÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ü¸®µÈ ³ó¾÷ ½Ã½ºÅÛ¿¡¼­ »çÀÌÅäŰ´ÑÀÇ »ç¿ë·®ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½Ä¹° ¼ºÀå Á¶ÀýÁ¦¸¦ °ü¸®ÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©µµ ½ÃÀå ¿ªÇÐÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ȯ°æº¸È£Ã»(EPA)À̳ª À¯·´½Äǰ¾ÈÀüû(EFSA)°ú °°Àº ±â°üÀº ÇÕ¼º È£¸£¸óÀÇ Àû¿ë¿¡ ´ëÇØ º¸´Ù ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» ½ÃÇàÇϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷üµéÀÌ È¯°æ ģȭÀûÀÎ »çÀÌÅäŰ´Ñ Á¦Á¦¸¦ °³¹ßÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ°¡ Áö¿øÇÏ´Â ³ó¾÷ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÅäŰ´Ñ ±â¹Ý ÀÛ¹° °³·® ÇÁ·Î±×·¥À» Áö¿øÇÏ¿© »ê¾÷ÀÇ Ãß°¡ È®ÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÅäŰ´Ñ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

»çÀÌÅäŰ´Ñ ½ÃÀåÀÇ ¼ºÀåÀº °í¼öÀÍ ³ó¾÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹ÙÀÌ¿À ÀÚ±ØÁ¦ ±â¼ú ¹ßÀü, Áö¼Ó °¡´ÉÇÑ ³ó¹ý¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿øÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ±âÈÄ º¯È­¿¡ °­ÇÑ ÀÛ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÅäŰ´Ñ ¿¬±¸¸¦ °¡¼ÓÈ­Çϰí ÀÖÀ¸¸ç, ƯÈ÷ °¡¹³¿¡ Ãë¾àÇÑ Áö¿ª¿¡¼­´Â ¹° È¿À²ÀÌ ³ôÀº ³ó¾÷ÀÌ Áß¿äÇÕ´Ï´Ù.

ÃÖÁ¾ ¿ëµµÀÇ È®´ëµµ Áß¿äÇÑ ÃËÁø¿äÀÎÀ¸·Î, ½ÃÅäŰ´ÑÀº È­ÈÑ Àç¹è, ¿ø¿¹, °úÀÏ º¸Á¸¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. À¯±â³ó ½Äǰ »ý»êÀÇ ºÎ»óµµ »ý»êÀÚµéÀÌ ÀÚ¿¬ ½Ä¹° ¼ºÀå ¼Ö·ç¼ÇÀ» Ãß±¸Çϱ⠶§¹®¿¡ ½ÃÅäŰ´ÑÀÇ Ã¤Å÷ü »ó½Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ó¾÷ ±â¼ú ±â¾÷°ú Á¾ÀÚ È¸»çÀÇ Á¦ÈÞ´Â »çÀÌÅäŰ´ÑÀ» ±â¹ÝÀ¸·Î ÇÑ ÀÛ¹° °­È­ Àü·«ÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°è ½Ä·® ¾Èº¸ÀÇ µµÀüÀÌ °è¼Ó Áõ°¡ÇÏ´Â °¡¿îµ¥, ½ÃÅäŰ´Ñ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̸ç Çö´ë ³ó¾÷ÀÇ ¹Ì·¡¸¦ Çü¼ºÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

À¯Çü(¾Æµ¥´Ñ ŸÀÔ, Æä´Ò ŸÀÔ, ±âŸ À¯Çü), ±â´É(¼¼Æ÷ ºÐ¿­ ÀÚ±Ø, ³ëÈ­, °³È­ À¯µµ, ½Ä¹° ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö, ±âŸ ±â´É), ÃÖÁ¾ ¿ëµµ(³ó¾÷, ¿ø¿¹, ¼ÒºñÀÚ ºÎ¹®, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cytokinins Market to Reach US$2.8 Billion by 2030

The global market for Cytokinins estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Adenine-Type Cytokinins, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Phenyl-Type Cytokinins segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$535.9 Million While China is Forecast to Grow at 10.0% CAGR

The Cytokinins market in the U.S. is estimated at US$535.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$586.1 Million by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Cytokinins Market - Key Trends & Growth Drivers Summarized

Why Are Cytokinins Gaining Importance in Modern Agriculture?

Cytokinins, a class of plant growth regulators, play a crucial role in cell division, growth promotion, and delaying leaf senescence, making them indispensable in modern agriculture. These phytohormones are widely used in crop enhancement, tissue culture, and stress resistance management. With increasing global food demand and climate change impacting agricultural productivity, cytokinins are being utilized to improve crop yields, enhance drought tolerance, and extend post-harvest shelf life.

The rise of precision farming and controlled-environment agriculture (CEA) has further fueled cytokinin adoption. Greenhouse farming, hydroponics, and aeroponics rely on cytokinin-based formulations to optimize plant growth under controlled conditions. Additionally, biotechnology-driven advancements in plant genetics have paved the way for cytokinin-enriched bio-stimulants, offering sustainable alternatives to chemical fertilizers. As agribusinesses and research institutions focus on maximizing crop output, the demand for cytokinins is expected to grow.

What Are the Latest Innovations in Cytokinin-Based Agriculture?

Recent innovations in cytokinin formulations have enhanced their efficacy and application efficiency. Microencapsulation technology is being used to develop slow-release cytokinin products that provide prolonged plant stimulation, reducing the need for frequent applications. Additionally, advancements in nano-formulations have improved cytokinin absorption, ensuring better plant uptake and minimizing environmental runoff.

Another breakthrough is the integration of cytokinins into bioengineered crops. Researchers are using gene-editing techniques, such as CRISPR, to enhance cytokinin expression in plants, leading to improved growth rates and stress resistance. AI-powered agritech platforms are also helping farmers optimize cytokinin use by analyzing soil conditions and plant health in real-time. These innovations are making cytokinins more effective and sustainable in large-scale farming operations.

How Are Market Trends and Regulatory Policies Impacting Cytokinin Adoption?

The growing demand for organic and sustainable farming solutions has influenced cytokinin market trends. Many agricultural producers are shifting toward natural cytokinin sources, such as seaweed extracts and microbial bio-stimulants, to reduce reliance on synthetic chemicals. Additionally, the increasing adoption of vertical farming and indoor cultivation has led to higher cytokinin usage in controlled agricultural systems.

Regulatory frameworks governing plant growth regulators are also shaping market dynamics. Agencies such as the U.S. Environmental Protection Agency (EPA) and the European Food Safety Authority (EFSA) are enforcing stricter guidelines on synthetic hormone applications, encouraging manufacturers to develop eco-friendly cytokinin formulations. Furthermore, government-backed agricultural research initiatives are supporting cytokinin-based crop improvement programs, driving further industry expansion.

What Is Driving the Growth of the Cytokinins Market?

The growth in the cytokinins market is driven by the increasing need for high-yield agriculture, advancements in bio-stimulant technologies, and regulatory support for sustainable farming practices. The demand for climate-resilient crops has accelerated cytokinin research, particularly in drought-prone regions where water-efficient farming is critical.

End-use expansion is another key driver, with cytokinins finding applications in floriculture, horticulture, and fruit preservation. The rise of organic food production has also contributed to higher cytokinin adoption, as growers seek natural plant growth solutions. Additionally, partnerships between agritech firms and seed companies are fostering innovation in cytokinin-based crop enhancement strategies. As global food security challenges continue to rise, the cytokinin market is expected to witness sustained growth, shaping the future of modern agriculture.

SCOPE OF STUDY:

The report analyzes the Cytokinins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Adenine-Type Cytokinins, Phenyl-Type Cytokinins, Other Types); Function (Cell Division Stimulation Function, Senescence Function, Flowering Induction Function, Plant Biotechnology Function, Other Functions); End-Use (Agriculture End-Use, Horticulture End-Use, Consumer Sector End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â